These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 29940579)

  • 1. Feasibility of Smartphone-Based Testing of Interference in Parkinson's Disease.
    Lee W; Williams DR; Evans A
    Neurodegener Dis; 2018; 18(2-3):133-142. PubMed ID: 29940579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of a Smartphone Application Measuring Motor Function in Parkinson's Disease.
    Lee W; Evans A; Williams DR
    J Parkinsons Dis; 2016 Apr; 6(2):371-82. PubMed ID: 27061062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive impairment in Parkinson's disease: Association between patient-reported and clinically measured outcomes.
    Mills KA; Mari Z; Pontone GM; Pantelyat A; Zhang A; Yoritomo N; Powers E; Brandt J; Dawson TM; Rosenthal LS
    Parkinsonism Relat Disord; 2016 Dec; 33():107-114. PubMed ID: 27733275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Parkinson's Disease Composite Scale: results of the first validation study.
    Stocchi F; Radicati FG; Chaudhuri KR; Johansson A; Padmakumar C; Falup-Pecurariu C; Martinez-Martin P
    Eur J Neurol; 2018 Mar; 25(3):503-511. PubMed ID: 29193455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between the non-motor items of the MDS-UPDRS and Quality of Life in patients with Parkinson's disease.
    Skorvanek M; Rosenberger J; Minar M; Grofik M; Han V; Groothoff JW; Valkovic P; Gdovinova Z; van Dijk JP
    J Neurol Sci; 2015; 353(1-2):87-91. PubMed ID: 25918077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of a timed motor test battery to the Unified Parkinson's Disease Rating Scale-III in Parkinson's disease.
    Haaxma CA; Bloem BR; Borm GF; Horstink MW
    Mov Disord; 2008 Sep; 23(12):1707-17. PubMed ID: 18649395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computerized testing in Parkinson's disease: Performance deficits in relation to standard clinical measures.
    Flannery SL; Jowett T; Garvey A; Cutfield NJ; Machado L
    J Clin Exp Neuropsychol; 2018 Dec; 40(10):1062-1073. PubMed ID: 29978753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results.
    Goetz CG; Tilley BC; Shaftman SR; Stebbins GT; Fahn S; Martinez-Martin P; Poewe W; Sampaio C; Stern MB; Dodel R; Dubois B; Holloway R; Jankovic J; Kulisevsky J; Lang AE; Lees A; Leurgans S; LeWitt PA; Nyenhuis D; Olanow CW; Rascol O; Schrag A; Teresi JA; van Hilten JJ; LaPelle N;
    Mov Disord; 2008 Nov; 23(15):2129-70. PubMed ID: 19025984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan.
    Goetz CG; Fahn S; Martinez-Martin P; Poewe W; Sampaio C; Stebbins GT; Stern MB; Tilley BC; Dodel R; Dubois B; Holloway R; Jankovic J; Kulisevsky J; Lang AE; Lees A; Leurgans S; LeWitt PA; Nyenhuis D; Olanow CW; Rascol O; Schrag A; Teresi JA; Van Hilten JJ; LaPelle N
    Mov Disord; 2007 Jan; 22(1):41-7. PubMed ID: 17115387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conscious attention defect and inhibitory control deficit in Parkinson's Disease-Mild Cognitive Impairment: A comparison study with Amnestic Mild Cognitive Impairment multiple domain.
    Cammisuli DM; Sportiello MT
    Psychiatr Danub; 2017 Dec; 29(4):437-445. PubMed ID: 29197200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessing the non-motor symptoms of Parkinson's disease: MDS-UPDRS and NMS Scale.
    Martinez-Martin P; Chaudhuri KR; Rojo-Abuin JM; Rodriguez-Blazquez C; Alvarez-Sanchez M; Arakaki T; Bergareche-Yarza A; Chade A; Garretto N; Gershanik O; Kurtis MM; Martinez-Castrillo JC; Mendoza-Rodriguez A; Moore HP; Rodriguez-Violante M; Singer C; Tilley BC; Huang J; Stebbins GT; Goetz CG
    Eur J Neurol; 2015 Jan; 22(1):37-43. PubMed ID: 23607783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of the Hebrew version of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale.
    Zitser J; Peretz C; Ber David A; Shabtai H; Ezra A; Kestenbaum M; Brozgol M; Rosenberg A; Herman T; Balash Y; Gadoth A; Thaler A; Stebbins GT; Goetz CG; Tilley BC; Luo ST; Liu Y; Giladi N; Gurevich T
    Parkinsonism Relat Disord; 2017 Dec; 45():7-12. PubMed ID: 28965872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical characteristics in Parkinson's disease patients with cognitive impairment and effects of cognitive impairment on sleep].
    Gong Y; Xiong KP; Mao CJ; Huang JY; Hu WD; Han F; Chen R; Liu CF
    Zhonghua Yi Xue Za Zhi; 2013 Sep; 93(33):2637-41. PubMed ID: 24360043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detecting and monitoring the symptoms of Parkinson's disease using smartphones: A pilot study.
    Arora S; Venkataraman V; Zhan A; Donohue S; Biglan KM; Dorsey ER; Little MA
    Parkinsonism Relat Disord; 2015 Jun; 21(6):650-3. PubMed ID: 25819808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation among olfactory function, motors' symptoms, cognitive impairment, apathy, and fatigue in patients with Parkinson's disease.
    Masala C; Solla P; Liscia A; Defazio G; Saba L; Cannas A; Cavazzana A; Hummel T; Haehner A
    J Neurol; 2018 Aug; 265(8):1764-1771. PubMed ID: 29804147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal Fluid C-Reactive Protein in Parkinson's Disease: Associations with Motor and Non-motor Symptoms.
    Sanjari Moghaddam H; Valitabar Z; Ashraf-Ganjouei A; Mojtahed Zadeh M; Ghazi Sherbaf F; Aarabi MH
    Neuromolecular Med; 2018 Sep; 20(3):376-385. PubMed ID: 29980980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive profile of Parkinson's disease patients: a comparative study between early-onset and late-onset Parkinson's disease.
    Tang H; Huang J; Nie K; Gan R; Wang L; Zhao J; Huang Z; Zhang Y; Wang L
    Int J Neurosci; 2016; 126(3):227-34. PubMed ID: 26001202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Motor and Cognitive Symptoms with Health-Related Quality of Life and Caregiver Burden in a German Cohort of Advanced Parkinson's Disease Patients.
    Klietz M; Schnur T; Drexel S; Lange F; Tulke A; Rippena L; Paracka L; Dressler D; Höglinger GU; Wegner F
    Parkinsons Dis; 2020; 2020():5184084. PubMed ID: 32184980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expanded and independent validation of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS).
    Martinez-Martin P; Rodriguez-Blazquez C; Alvarez-Sanchez M; Arakaki T; Bergareche-Yarza A; Chade A; Garretto N; Gershanik O; Kurtis MM; Martinez-Castrillo JC; Mendoza-Rodriguez A; Moore HP; Rodriguez-Violante M; Singer C; Tilley BC; Huang J; Stebbins GT; Goetz CG
    J Neurol; 2013 Jan; 260(1):228-36. PubMed ID: 22865238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of the Italian version of the Non Motor Symptoms Scale for Parkinson's disease.
    Cova I; Di Battista ME; Vanacore N; Papi CP; Alampi G; Rubino A; Valente M; Meco G; Contri P; Di Pucchio A; Lacorte E; Priori A; Mariani C; Pomati S
    Parkinsonism Relat Disord; 2017 Jan; 34():38-42. PubMed ID: 28029554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.